Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 170,598 | 173,782 | 198,283 | 190,411 | 140,959 |
| Marketable Securities | 72,824 | 79,397 | 43,522 | 40,105 | 32,454 |
| Receivables | 7,248 | 10,448 | 7,692 | 18,088 | 5,937 |
| TOTAL | $256,581 | $266,516 | $253,462 | $252,309 | $184,001 |
| Non-Current Assets | |||||
| PPE Net | 122,818 | 123,657 | 124,774 | 126,264 | 127,613 |
| Investments And Advances | 53,155 | 71,010 | 98,730 | 111,540 | 122,009 |
| Other Non-Current Assets | 9,202 | 8,369 | 9,247 | 9,016 | 8,912 |
| TOTAL | $185,175 | $203,036 | $232,751 | $246,820 | $258,534 |
| Total Assets | $441,756 | $469,552 | $486,213 | $499,129 | $442,535 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,950 | 6,223 | 2,039 | 3,474 | 1,543 |
| Accrued Expenses | 49,179 | 50,914 | 51,748 | 47,942 | 44,038 |
| TOTAL | $60,113 | $65,125 | $61,744 | $66,443 | $58,303 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 7,984 | 7,988 | 7,957 | 15,027 | 12,722 |
| Other Non-Current Liabilities | 20,992 | 21,045 | 20,501 | 20,506 | 21,023 |
| TOTAL | $230,671 | $229,318 | $226,853 | $220,309 | $208,009 |
| Total Liabilities | $290,784 | $294,443 | $288,597 | $286,752 | $266,312 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,798 | 2,556 | 2,526 | 2,512 | 2,498 |
| Common Shares | 644 | 637 | 631 | 627 | 624 |
| Retained earnings | -502,903 | -469,742 | -435,740 | -411,586 | -435,903 |
| Other shareholders' equity | 18,251 | 18,311 | 17,938 | 18,247 | 17,567 |
| TOTAL | $150,972 | $175,109 | $197,616 | $212,377 | $176,223 |
| Total Liabilities And Equity | $441,756 | $469,552 | $486,213 | $499,129 | $442,535 |